Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
81.80
-0.73 (-0.88%)
Nov 21, 2024, 12:12 PM EST - Market open

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $2.50 billion. The enterprise value is $2.44 billion.

Market Cap 2.50B
Enterprise Value 2.44B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

Belite Bio has 30.61 million shares outstanding. The number of shares has increased by 15.58% in one year.

Current Share Class n/a
Shares Outstanding 30.61M
Shares Change (YoY) +15.58%
Shares Change (QoQ) +1.20%
Owned by Insiders (%) 2.76%
Owned by Institutions (%) 0.49%
Float 12.67M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 22.71
P/TBV Ratio 22.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 30.73

Current Ratio 30.73
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,419.76

Financial Efficiency

Return on equity (ROE) is -40.04% and return on invested capital (ROIC) is -26.89%.

Return on Equity (ROE) -40.04%
Return on Assets (ROA) -25.58%
Return on Capital (ROIC) -26.89%
Revenue Per Employee n/a
Profits Per Employee -$1.65M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Belite Bio has paid $5,000 in taxes.

Income Tax 5,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +121.86% in the last 52 weeks. The beta is -1.60, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y) -1.60
52-Week Price Change +121.86%
50-Day Moving Average 61.25
200-Day Moving Average 49.39
Relative Strength Index (RSI) 72.28
Average Volume (20 Days) 112,307

Short Selling Information

Short Interest 233,985
Short Previous Month 270,587
Short % of Shares Out 1.85%
Short % of Float n/a
Short Ratio (days to cover) 3.71

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -35.49M
Pretax Income -31.62M
Net Income -33.03M
EBITDA -35.30M
EBIT -35.49M
Earnings Per Share (EPS) -$1.11
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) 112.20M
Book Value Per Share 3.63
Working Capital 107.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.58%
Shareholder Yield -15.58%
Earnings Yield -1.31%
FCF Yield n/a

Analyst Forecast

The average price target for Belite Bio is $89.00, which is 8.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target $89.00
Price Target Difference 8.80%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1